Literature DB >> 19882676

Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders.

Amy J McKnight1, Diane Currie, Alexander P Maxwell.   

Abstract

Chronic kidney disease is common with up to 5% of the adult population reported to have an estimated glomerular filtration rate of < 60 ml/min/1.73 m(2). A large number of pathogenic mutations have been identified that are responsible for 'single gene' renal disorders, such as autosomal dominant polycystic kidney disease and X-linked Alport syndrome. These single gene disorders account for < 15% of the burden of end-stage renal disease that requires dialysis or kidney transplantation. It has proved more difficult to identify the genetic susceptibility underlying common, complex, multifactorial kidney conditions, such as diabetic nephropathy and hypertensive nephrosclerosis. This review describes success to date and explores strategies currently employed in defining the genetic basis for a number of renal disorders. The complementary use of linkage studies, candidate gene and genome-wide association analyses are described and a collation of renal genetic resources highlighted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19882676     DOI: 10.1002/path.2639

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

1.  Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure.

Authors:  Prasad R Konkalmatt; Laureano D Asico; Yanrong Zhang; Yu Yang; Cinthia Drachenberg; Xiaoxu Zheng; Fei Han; Pedro A Jose; Ines Armando
Journal:  JCI Insight       Date:  2016-06-02

Review 2.  Genetics of diabetic nephropathy: a long road of discovery.

Authors:  Amy Jayne McKnight; Seamus Duffy; Alexander P Maxwell
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

3.  Diagnosis of Alport syndrome--search for proteomic biomarkers in body fluids.

Authors:  Michael Pohl; Karin Danz; Oliver Gross; Ulrike John; Johannes Urban; Ludwig Patzer; Sandra Habbig; Markus Feldkötter; Oliver Witzke; Mario Walther; Heidrun Rhode
Journal:  Pediatr Nephrol       Date:  2013-06-23       Impact factor: 3.714

Review 4.  The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus.

Authors:  Saharon Rosset; Shay Tzur; Doron M Behar; Walter G Wasser; Karl Skorecki
Journal:  Nat Rev Nephrol       Date:  2011-05-03       Impact factor: 28.314

5.  MiR-217 mediates the protective effects of the dopamine D2 receptor on fibrosis in human renal proximal tubule cells.

Authors:  Fei Han; Prasad Konkalmatt; Jianghua Chen; John Gildea; Robin A Felder; Pedro A Jose; Ines Armando
Journal:  Hypertension       Date:  2015-03-23       Impact factor: 10.190

6.  Identifying biomarkers as diagnostic tools in kidney transplantation.

Authors:  Valeria R Mas; Thomas F Mueller; Kellie J Archer; Daniel G Maluf
Journal:  Expert Rev Mol Diagn       Date:  2011-03       Impact factor: 5.225

Review 7.  CRISPR Gene Editing in the Kidney.

Authors:  Nelly M Cruz; Benjamin S Freedman
Journal:  Am J Kidney Dis       Date:  2018-03-30       Impact factor: 8.860

8.  Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells.

Authors:  Xiaoliang Jiang; Prasad Konkalmatt; Yu Yang; John Gildea; John E Jones; Santiago Cuevas; Robin A Felder; Pedro A Jose; Ines Armando
Journal:  Hypertension       Date:  2013-12-30       Impact factor: 10.190

9.  DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease.

Authors:  Laura J Smyth; Gareth J McKay; Alexander P Maxwell; Amy Jayne McKnight
Journal:  Epigenetics       Date:  2013-11-19       Impact factor: 4.528

10.  Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy.

Authors:  Winfred W Williams; Rany M Salem; Amy Jayne McKnight; Niina Sandholm; Carol Forsblom; Andrew Taylor; Candace Guiducci; Jarred B McAteer; Gareth J McKay; Tamara Isakova; Eoin P Brennan; Denise M Sadlier; Cameron Palmer; Jenny Söderlund; Emma Fagerholm; Valma Harjutsalo; Raija Lithovius; Daniel Gordin; Kustaa Hietala; Janne Kytö; Maija Parkkonen; Milla Rosengård-Bärlund; Lena Thorn; Anna Syreeni; Nina Tolonen; Markku Saraheimo; Johan Wadén; Janne Pitkäniemi; Cinzia Sarti; Jaakko Tuomilehto; Karl Tryggvason; Anne-May Österholm; Bing He; Steve Bain; Finian Martin; Catherine Godson; Joel N Hirschhorn; Alexander P Maxwell; Per-Henrik Groop; Jose C Florez
Journal:  Diabetes       Date:  2012-06-20       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.